Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Toronto
$105,000.00
The Effects of Lipid Virulence Factors, PDIMs/PGLs, on Virulence and Immunogenicity of BCG Vaccine Strains
FY 2008-09
Summary
Tuberculosis (TB), caused by Mycobacterium tuberculosis, continues to be a global health problem. Currently, BCG is the only vaccine available for TB but its effectiveness is very poor against pulmonary TB in adults. The use of BCG worldwide has created many genetically different strains. However, the ability of each strain to protect against TB is unknown and their virulence and capacity to cause side effects varies. Our lab has discovered a molecular mechanism that contributes to the variability in virulence between BCG strains. We found that three of the BCG strains (BCG-Japan, -Moreau, and -Glaxo) do not produce two cell wall lipids, PDIMs and PGLs, which are important for virulence. We also found a genetic deletion that accounts for the absence of these lipids in BCG-Moreau. Furthermore, a strong correlation was found between the production of PDIMs/PGLs and the risk of BCG complications observed in clinical studies. My project aims to investigate the effect of these lipids on BCG vaccine properties. I hypothesize that the presence of PDIMs/PGLs confers a survival advantage for BCG strains in the host and induces an immune response that correlates with its ability to cause side effects. To test my hypothesis, I will first generate PDIM/PGL knock-out BCG strains that do not produce PDIMs/PGLs. I will use these strains in macrophage and mice infection experiments to investigate whether there is a survival advantage for BCG strains containing PDIMs/PGLs and whether there is a significant variation in immune responses elicited by the mice. My research aims to elucidate the differences in virulence and immunogenicity between the BCG strains. Correlating these differences to the production of PDIMs/PGLs offers a useful means to assess potential BCG-induced complications. This will aid in determining the safest strain that should be used for vaccination in an attempt to reduce the risk of BCG disease, which is currently a major challenge in HIV-endemic countries.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
184613
Name
Tran Linh Vanessa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The Effects of Lipid Virulence Factors, PDIMs/PGLs, on Virulence and Immunogenicity of BCG Vaccine Strains
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Bcg; Cell Wall Lipids; Infection; Molecular Genetics; Tuberculosis; Vaccine
Abstract
Tuberculosis (TB), caused by Mycobacterium tuberculosis, continues to be a global health problem. Currently, BCG is the only vaccine available for TB but its effectiveness is very poor against pulmonary TB in adults. The use of BCG worldwide has created many genetically different strains. However, the ability of each strain to protect against TB is unknown and their virulence and capacity to cause side effects varies. Our lab has discovered a molecular mechanism that contributes to the variability in virulence between BCG strains. We found that three of the BCG strains (BCG-Japan, -Moreau, and -Glaxo) do not produce two cell wall lipids, PDIMs and PGLs, which are important for virulence. We also found a genetic deletion that accounts for the absence of these lipids in BCG-Moreau. Furthermore, a strong correlation was found between the production of PDIMs/PGLs and the risk of BCG complications observed in clinical studies. My project aims to investigate the effect of these lipids on BCG vaccine properties. I hypothesize that the presence of PDIMs/PGLs confers a survival advantage for BCG strains in the host and induces an immune response that correlates with its ability to cause side effects. To test my hypothesis, I will first generate PDIM/PGL knock-out BCG strains that do not produce PDIMs/PGLs. I will use these strains in macrophage and mice infection experiments to investigate whether there is a survival advantage for BCG strains containing PDIMs/PGLs and whether there is a significant variation in immune responses elicited by the mice. My research aims to elucidate the differences in virulence and immunogenicity between the BCG strains. Correlating these differences to the production of PDIMs/PGLs offers a useful means to assess potential BCG-induced complications. This will aid in determining the safest strain that should be used for vaccination in an attempt to reduce the risk of BCG disease, which is currently a major challenge in HIV-endemic countries.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tran, Linh Vanessa
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~